WeiQing LIU

ORCID: 0000-0003-4474-9294
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Research and Treatments
  • RNA Interference and Gene Delivery
  • Virus-based gene therapy research
  • Reconstructive Surgery and Microvascular Techniques

Shanghai University of Traditional Chinese Medicine
2025

First Affiliated Hospital of Kunming Medical University
2012

Kunming Medical University
2012

Background : Cisplatin is a cytotoxic compound that has low selectivity to cancer cells and may cause serious adverse reactions, including acute kidney injury (AKI). Oxidative stress inflammation are the main causes of cisplatin-induced AKI (CIAKI). Mangiferin polyphenolic xanthonoid possesses extraordinary antioxidant anti-inflammatory properties. The purpose this investigation was ascertain potential renal protective mechanism mangiferin in alleviating CIAKI. Methods We assayed serum...

10.1177/1934578x251325035 article EN cc-by-nc Natural Product Communications 2025-03-01

Plastic and Reconstructive Surgery: June 2010 - Volume 125 Issue 6 p 120 doi: 10.1097/01.prs.0000371916.78852.03

10.1097/01.prs.0000371916.78852.03 article EN Plastic & Reconstructive Surgery 2010-04-28

To investigate the effects of a breast-cancer-specific peptide (PI)-enhanced green fluorescent protein (EGFP) fusion in vivo and PI-HSV-tk/GCV system vitro , transduction efficiency PI-EGFP was tested MDA-MB-231 MDA-MB-435 cells. Mice were also injected with via tail vein its distribution relation to local tumors observed . The recombinant plasmid pET-28a (+)-PI-tk constructed PI-HSV-tk then detected cells by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) Western...

10.1360/972011-262 article EN Chinese Science Bulletin (Chinese Version) 2012-04-01
Coming Soon ...